American Society of Hematology Annual Meeting 2014: highlights in multiple myeloma

被引：5
作者：
Glavey, Siobhan V. [1 ]
Ghobrial, Irene M. [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源：
EXPERT REVIEW OF HEMATOLOGY | 2015年 / 8卷 / 03期
关键词：
DEXAMETHASONE; LENALIDOMIDE;
D O I：
10.1586/17474086.2015.1029449
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 275
页数：3
相关论文
共 21 条
[1]  
[Anonymous], BLOOD
[2]  
[Anonymous], 2014, BLOOD, V124, P4746
[3]  
[Anonymous], 2014, BLOOD, V124, P3416
[4]  
Boyle EM, 2014, BLOOD, V124, P637
[5]   Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors [J].
de Weers, Michel ;
Tai, Yu-Tzu ;
van der Veer, Michael S. ;
Bakker, Joost M. ;
Vink, Tom ;
Jacobs, Danielle C. H. ;
Oomen, Lukas A. ;
Peipp, Matthias ;
Valerius, Thomas ;
Slootstra, Jerry W. ;
Mutis, Tuna ;
Bleeker, Wim K. ;
Anderson, Kenneth C. ;
Lokhorst, Henk M. ;
van de Winkel, Jan G. J. ;
Parren, Paul W. H. I. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (03) :1840-1848
[6]   In Multiple Myeloma, Minimal Residual Disease (MRD) Is an Early Predictor of Progression and Is Modulated By Maintenance Therapy with Lenalidomide [J].
Gambella, Manuela ;
Omede, Paola ;
Oliva, Stefania ;
Gilestro, Milena ;
Muccio, Vittorio Emanuele ;
Drandi, Daniela ;
Ferrero, Simone ;
Gay, Francesca ;
Patriarca, Francesca ;
Palladino, Carmela ;
Petrucci, Maria Teresa ;
Pescosta, Norbert ;
Liberati, Anna Marina ;
Caravita, Tommaso ;
Di Raimondo, Francesco ;
Rocci, Alberto ;
Musto, Pellegrino ;
Boccadoro, Mario ;
Palumbo, Antonio .
BLOOD, 2014, 124 (21)
[7]   Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease [J].
Kastritis, E. ;
Terpos, E. ;
Moulopoulos, L. ;
Spyropoulou-Vlachou, M. ;
Kanellias, N. ;
Eleftherakis-Papaiakovou, E. ;
Gkotzamanidou, M. ;
Migkou, M. ;
Gavriatopoulou, M. ;
Roussou, M. ;
Tasidou, A. ;
Dimopoulos, M. A. .
LEUKEMIA, 2013, 27 (04) :947-953
[8]  
Martin TG, 2014, BLOOD, V124, P83
[9]   Comparison of Sequential Vs Alternating Administration of Bortezomib, Melphalan, Prednisone (VMP) and Lenalidomide Plus Dexamethasone (Rd) in Elderly Pts with Newly Diagnosed Multiple Myeloma (MM) Patients: GEM2010MAS65 Trial [J].
Mateos, Maria-Victoria ;
Martinez-Lopez, Joaquin ;
Hernandez, Miguel-T ;
Martinez, Rafael ;
Rosinol, Laura ;
Ocio, Enrique M. ;
Asuncion Echeveste, Maria ;
Perez de Oteyza, Jaime ;
Oriol, Albert ;
Bargay, Joan ;
Gironella, Mercedes ;
Martin, Jesus ;
Cabrera, Carmen ;
De La Rubia, Javier ;
Gutierrez, Norma C. ;
Martin, Maria-Luisa ;
Paiva, Bruno ;
Angeles Montalban, Maria ;
Blade, Joan ;
Jose Lahuerta, Juan ;
San Miguel, Jesus F. .
BLOOD, 2014, 124 (21)
[10]   Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma [J].
Mateos, Maria-Victoria ;
Hernandez, Miguel-Teodoro ;
Giraldo, Pilar ;
de la Rubia, Javier ;
de Arriba, Felipe ;
Lopez Corral, Lucia ;
Rosinol, Laura ;
Paiva, Bruno ;
Palomera, Luis ;
Bargay, Joan ;
Oriol, Albert ;
Prosper, Felipe ;
Lopez, Javier ;
Olavarria, Eduardo ;
Quintana, Nuria ;
Garcia, Jose-Luis ;
Blade, Joan ;
Lahuerta, Juan-Jose ;
San Miguel, Jesus-F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05) :438-447
123